Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $13.30 Analyst target: $30.67 Upside: 130.60%
MediWound Ltd., a biopharmaceutical company, develops, manufactures and markets new and biotherapeutic solutions for tissue repair and regeneration. The company is headquartered in Yavne, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.